$ガルメド ファーマシューティカルズ(GLMD.US)$On March 19, Galmed Pharmaceuticals Got Letter From Nasdaq That Granted Co Additional 180 Calendar Day Period To Regain Compliance Benzinga· 1 min ago
$ガルメド ファーマシューティカルズ(GLMD.US)$Galmed Announces Grant Of New Patent For Combination Of Aramchol With Resmetirom (MGL-3196, REZDIFFRA) For Treatment Of NASH And Liver Fibrosis
2
1
報告
Trytosaveabitスレ主 :
Inventiva said the Phase 2 proof-of-concept study met its primary endpoint with an absolute reduction of HbA1c of 1.14% to 1.59% in patients treated with lanifibranor or in combination with empagliflozin at week 24 versus an increase of 0.26% in the placebo arm. Patients treated with the combination also were able to maintain a stable weight throughout the 24 weeks of the study.
$ガルメド ファーマシューティカルズ(GLMD.US)$ Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study TEL AVIV, Israel, November 20, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced today a delay of at least 6 months in the initiation of its Primary Sclerosing Cholangitis (PSC) Ph 2a Study. In May ...
Trytosaveabitスレ主Tom2808:
Yes in the short term! Investors were hoping to have that information by EOY or so? Now it’s going to be 6+ months according to that PR. GL
Trytosaveabitスレ主T-24Century:
I thought at first? But it was getting great volume for a AH P&D? So I thought as long as it’s left alone it would break a buck
ガルメド ファーマシューティカルズに関するコメント
Benzinga· 1 min ago
i m bought n dead 🤣
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
TEL AVIV, Israel, November 20, 2023 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) (“Galmed” or the “Company”), a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced today a delay of at least 6 months in the initiation of its Primary Sclerosing Cholangitis (PSC) Ph 2a Study.
In May ...
まだコメントはありません